Endometrial Ablation

Endometrial Ablation

Women with menorrhagia who do not wish to have children and for whom medical therapy has not provided relief from their heavy bleeding may be candidates for a procedure called endometrial ablation, which stops or reduces heavy bleeding by destroying the lining of the uterus.  The procedure is minimally invasive, which means that it can be done on an outpatient basis or even in the gynecologist’s office if the doctor has the appropriate training and equipment to perform it.

Different approaches may use electricity, heat or freezing to destroy the uterine lining.  Studies have shown that over 90% of women who have had endometrial ablation experience relief from their heavy periods.  Furthermore, because it is minimally invasive, endometrial ablation avoids the costs and risks of hysterectomy, and patients are able to be back to their normal routines within a day or two.

There are some women for whom this procedure does not work, and these women may require additional surgeries or even hysterectomy.  The success of endometrial ablation as compared to hysterectomy for menorrhagia was compared recently in a large study conducted in both U.S. and Canadian clinical centers.  The researchers concluded that endometrial ablation provides satisfactory control of abnormal uterine bleeding for the majority of women, with many fewer complications than hysterectomy.  However, about 31% of those who had endometrial ablation had a return of their symptoms within 5 years and ultimately elected to have a hysterectomy.  Other studies have shown better results.

In addition, there are cases of menorrhagia for which endometrial ablation is not appropriate.  For example, if menorrhagia was caused by fibroids, other treatment approaches are more likely to be successful and safe.

The procedure is not reliable as a sterilization, but pregnancy afterwards is rare since the uterine lining has been (mostly) destroyed.

Once the uterine lining (endometrium) has been destroyed, pregnancy is extremely risky. If only a few cells remain where the fetus may attach, it is likely that the placenta would develop abnormally and cause miscarriage or hemorrhage at the time of delivery. Thus, endometrial ablation is recommended only for women who are quite sure they no longer wish to have children.

Minerva/NovaSure® - Treatment for Heavy Periods


Minerva/NovaSure® is a quick, safe, simple, one-time endometrial ablation treatment for menorrhagia, abnormally heavy or lengthy menstruation.  It is an alternative to hysterectomy.  NovaSure gently removes the lining of the uterus with precisely measured electrical energy.  This quick simple procedure is performed as an in-office procedure and generally takes less than 5 minutes.  Unlike other ablation methods or hysterectomy, NovaSure does not involve hormones and has a quick recovery time—most women return to their regular activities the next day.


Traditional options for treating menorrhagia include endometrial ablation, hormones, dilation and curettage (D&C), or hysterectomy.  Unlike these traditional options, Minerva/NovaSure is a reliable method for relieving heavy menstrual bleeding that does not involve hormones, pre-hormone treatment, hysterectomy, or a long recovery time.  Minerva/NovaSure can be performed at anytime during your cycle.


Minerva/NovaSure is a one-time treatment that gently removes the uterine lining.  The state-of-the-art technology uses a slender wand to deliver a precise amount of electrical energy to remove the endometrial lining.  No incisions or stitches are needed.  Most women experience a significant reduction in their menstrual period bleeding.  Periods may decrease to a moderate or light flow, and some women experience no bleeding at all.  Many women report a reduction in pain and PMS symptoms as well.


Minerva/NovaSure is for premenopausal women with menorrhagia.  NovaSure is for women who have completed childbearing or are sure that they never want to have children.  Although the chance for pregnancy is reduced following Minerva/NovaSure, you will need to use contraception.  Pregnancy following Minerva/NovaSure is very dangerous for the mother and fetus.  Your doctor will discuss these issues, as well as the risks and benefits of the procedure, during your consultation.


Minerva/NovaSure is performed as an in-office treatment, surgical center or hospital based operation.  The procedure generally takes less than five minutes, which is significantly less than any other ablation method.  It does not require general anesthesia, incisions, or stitches (though some women prefer to have anesthesia).  You may receive an intravenous (IV) sedative to help you relax during the procedure and a local anesthetic to your cervix.  Your doctor will gently insert the treatment wand through your vagina and cervix to perform the ablation.  Some women report mild cramping during the procedure and others report no discomfort at all.


You may experience temporary cramping and discomfort following the procedure.  Some women experience a watery or bloody discharge for several weeks.  Minerva/NovaSure is generally associated with a rapid recovery time.  Your doctor will let you know how long to rest before resuming your regular activities.


  1. ACOG Committee on Practice Bulletins – Gynecology. ACOG Practice Bulletin: management of anovulatory bleeding. Intl J Gynaecol Obstet. 2001;72(3):263-71.
  2. American Society for Reproductive Medicine. Patient’s Fact Sheet: Endometrial Ablation. 2001.
  3. Lethaby A, et al. Endometrial destruction techniques for heavy menstrual bleeding. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD001501
  4. Lewin Group, Inc. Prevalence and treatment patterns of pelvic health disorders among U.S. women. National Women’s Health Resource Center 2007.
  5. McCausland AM, et al. Long-term complications of endometrial ablation: Cause, diagnosis, treatment, and prevention. J Min Invasive Gyn. 2007;14:399-406.
  6. Munro MG, et al. A randomized trial of hysterectomy versus endometrial ablation: Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB). Abstr. J Minimally Invasive Gynecol. 2006;13(5):S69.
  7. Munro M. Abnormal uterine bleeding in the reproductive years. Part III: Surgical management. J Am Assoc Gynecologic Laparoscopists. 8:18-48.
  8. Parker WH. A Gynecologist’s Second Opinion. 2003; A Plume Book; Published by the Penguin Group, New York, NY.